BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 73 filers reported holding BOLT BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $79,339 | -51.8% | 76,287 | -40.7% | 0.00% | – |
Q2 2023 | $164,667 | -37.4% | 128,646 | -32.0% | 0.00% | – |
Q1 2023 | $263,000 | +1011438.5% | 189,306 | +850.9% | 0.00% | – |
Q4 2022 | $26 | -99.1% | 19,908 | +742.1% | 0.00% | – |
Q3 2022 | $3,000 | 0.0% | 2,364 | +63.1% | 0.00% | – |
Q2 2022 | $3,000 | -98.3% | 1,449 | -97.8% | 0.00% | – |
Q1 2022 | $180,000 | -43.4% | 65,652 | +1.2% | 0.00% | – |
Q4 2021 | $318,000 | -63.1% | 64,860 | -4.7% | 0.00% | – |
Q3 2021 | $861,000 | -33.8% | 68,076 | -19.1% | 0.00% | – |
Q2 2021 | $1,300,000 | -84.3% | 84,099 | -66.5% | 0.00% | -100.0% |
Q1 2021 | $8,258,000 | – | 250,936 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $23,927,000 | 8.46% |
Nan Fung Group Holdings Ltd | 1,166,952 | $14,762,000 | 4.72% |
Novo Holdings A/S | 4,503,991 | $56,975,000 | 2.95% |
Vivo Capital, LLC | 3,871,291 | $48,972,000 | 2.20% |
Sofinnova Investments, Inc. | 2,754,437 | $34,844,000 | 2.06% |
Samsara BioCapital, LLC | 737,459 | $9,329,000 | 1.46% |
Ally Bridge Group (NY) LLC | 257,267 | $3,254,000 | 0.96% |
Board of Trustees of The Leland Stanford Junior University | 719,546 | $9,102,000 | 0.68% |
Rock Springs Capital Management LP | 1,649,248 | $20,863,000 | 0.44% |
RA Capital Management | 2,378,325 | $30,086,000 | 0.42% |